Alzheimer’s Disease- Roche (GRADUATE)
THIS STUDY IS UPCOMING!
The primary objective of this study is to slow cognitive and functional impairment in participants with early (mild or prodromal ) Alzheimer’s disease.
Age: 50 to 90 years of age
Indication: Mild Cognitive Impairment due to Alzheimer’s disease